Impact of the ABxSG Mobile Application on Antibiotic Prescribing: An Interrupted Time Series Study.

IF 4.6 2区 医学 Q1 INFECTIOUS DISEASES
Lai Wei Lee, Shena Yun Chun Lim, Yvonne Peijun Zhou, Shimin Jasmine Chung, De Zhi Chin, Andrea Lay Hoon Kwa, Winnie Hui Ling Lee
{"title":"Impact of the ABxSG Mobile Application on Antibiotic Prescribing: An Interrupted Time Series Study.","authors":"Lai Wei Lee, Shena Yun Chun Lim, Yvonne Peijun Zhou, Shimin Jasmine Chung, De Zhi Chin, Andrea Lay Hoon Kwa, Winnie Hui Ling Lee","doi":"10.3390/antibiotics14090933","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A point prevalence survey conducted at Singapore General Hospital in 2021 showed 48% of inpatients on antibiotics. We hypothesize that a mobile application, transforming complex antibiotic prescribing information into a succinct and individualized resource, will empower healthcare professionals and improve antibiotic prescriptions. Hence, we developed ABxSG using the behavioral design thinking approach (BDTA) to ensure positive user experience and sustained engagement. We aim to evaluate the impact of ABxSG on the proportion of inpatients on antibiotics, antibiotic appropriateness, and the number of antibiotic-related interventions by pharmacists.</p><p><strong>Methods: </strong>ABxSG was launched in March 2023. An interrupted time series analysis was conducted to evaluate its impact on the above outcomes measured using data collected from October 2021 to September 2024. There were 18 data points pre- and post-ABxSG.</p><p><strong>Results: </strong>Following the ABxSG launch, there was an immediate reduction in the proportion of inpatients on antibiotics by 1.66% (<i>p</i> < 0.01), followed by a sustained reduction of 3.12% at 18 months (<i>p</i> < 0.01). Piperacillin-tazobactam appropriateness increased by 2.76% at 1 month (<i>p</i> = 0.11) and further increased by 7.09% at 18 months (<i>p</i> < 0.05). Similarly, ceftriaxone appropriateness increased by 5.74% (<i>p</i> < 0.05) at 1 month and remained above pre-ABxSG levels. There was a significant increase in the number of pharmacist-led interventions for dosing optimization, with 96 more interventions/month at 18 months (<i>p</i> = 0.14).</p><p><strong>Conclusion: </strong>Antimicrobial stewardship teams must remain agile, embrace innovations, and adopt digital technologies to engage and empower clinicians. ABxSG reduced the proportion of inpatients on antibiotics and improved antibiotic prescriptions. The incorporation of BDTA in ABxSG, strong hospital leader support, and strategic planning to promote adoption led to its success.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"14 9","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12466656/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotics-Basel","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/antibiotics14090933","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A point prevalence survey conducted at Singapore General Hospital in 2021 showed 48% of inpatients on antibiotics. We hypothesize that a mobile application, transforming complex antibiotic prescribing information into a succinct and individualized resource, will empower healthcare professionals and improve antibiotic prescriptions. Hence, we developed ABxSG using the behavioral design thinking approach (BDTA) to ensure positive user experience and sustained engagement. We aim to evaluate the impact of ABxSG on the proportion of inpatients on antibiotics, antibiotic appropriateness, and the number of antibiotic-related interventions by pharmacists.

Methods: ABxSG was launched in March 2023. An interrupted time series analysis was conducted to evaluate its impact on the above outcomes measured using data collected from October 2021 to September 2024. There were 18 data points pre- and post-ABxSG.

Results: Following the ABxSG launch, there was an immediate reduction in the proportion of inpatients on antibiotics by 1.66% (p < 0.01), followed by a sustained reduction of 3.12% at 18 months (p < 0.01). Piperacillin-tazobactam appropriateness increased by 2.76% at 1 month (p = 0.11) and further increased by 7.09% at 18 months (p < 0.05). Similarly, ceftriaxone appropriateness increased by 5.74% (p < 0.05) at 1 month and remained above pre-ABxSG levels. There was a significant increase in the number of pharmacist-led interventions for dosing optimization, with 96 more interventions/month at 18 months (p = 0.14).

Conclusion: Antimicrobial stewardship teams must remain agile, embrace innovations, and adopt digital technologies to engage and empower clinicians. ABxSG reduced the proportion of inpatients on antibiotics and improved antibiotic prescriptions. The incorporation of BDTA in ABxSG, strong hospital leader support, and strategic planning to promote adoption led to its success.

Abstract Image

Abstract Image

Abstract Image

ABxSG移动应用程序对抗生素处方的影响:一项中断时间序列研究。
背景:2021年在新加坡综合医院进行的一项点患病率调查显示,48%的住院患者使用抗生素。我们假设移动应用程序,将复杂的抗生素处方信息转化为简洁和个性化的资源,将授权医疗保健专业人员和改善抗生素处方。因此,我们使用行为设计思维方法(BDTA)开发了ABxSG,以确保积极的用户体验和持续的用户粘性。我们的目的是评估ABxSG对住院患者使用抗生素比例、抗生素适宜性和药剂师抗生素相关干预次数的影响。方法:ABxSG于2023年3月上市。使用2021年10月至2024年9月收集的数据进行中断时间序列分析,以评估其对上述结果的影响。abxsg前后共有18个数据点。结果:ABxSG上市后,住院患者使用抗生素的比例立即下降1.66% (p < 0.01), 18个月后持续下降3.12% (p < 0.01)。1个月时哌拉西林-他唑巴坦适宜性增加2.76% (p = 0.11), 18个月时进一步增加7.09% (p < 0.05)。同样,1个月时头孢曲松适宜性增加5.74% (p < 0.05),仍高于abxsg前水平。药剂师主导的剂量优化干预措施数量显著增加,18个月时每月增加96项干预措施(p = 0.14)。结论:抗微生物药物管理团队必须保持敏捷,拥抱创新,并采用数字技术来吸引临床医生并赋予他们权力。ABxSG降低了住院患者使用抗生素的比例,改善了抗生素处方。将BDTA纳入ABxSG,医院领导的大力支持以及促进采用的战略规划导致了它的成功。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Antibiotics-Basel
Antibiotics-Basel Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
7.30
自引率
14.60%
发文量
1547
审稿时长
11 weeks
期刊介绍: Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信